• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 1015

3’-sialyllactose sodium salt

Intended Use: Intended for use as an ingredient at 0.28 g/L in formulas for young children (> 12 months); 0.9 g/L in milk- and soy-based meal replacement beverages for children and meal replacements drinks for adults; 1.0 g/kg in instant and ready-to-eat cereals for infants and young children under 3 years of age, snack bars, breakfast bars, and meal replacement bars; 0.45 g/L in non-carbonated sports drinks and flavored waters; and 1.5 g/L in food for enteral feeding.
Basis: Scientific procedures
Notifier: Chr. Hansen A/S
Notifier Address: 9015 West Maple Street
Milwaukee, WI 53214
GRAS Notice (releasable information): GRN 1015 with amendments (in PDF) (4.0 MB)
Date of closure: Jul 15, 2022
FDA's Letter: FDA has no questions (in PDF) (234 kB)

96  

-
-